Sunzen Group Berhad (KLSE:SUNZEN)

Market Cap	191.03M
Revenue (ttm)	77.29M -9.9%
Net Income	4.81M -2.6%
EPS	0.01 -16.2%
Shares Out	764.13M
PE Ratio	47.82
Forward PE	n/a
Dividend	0.00 (1.57%)
Ex-Dividend Date	Dec 12, 2025

Volume	162,000
Average Volume	660,445
Open	0.2550
Previous Close	0.2550
Day's Range	0.2500 - 0.2550
52-Week Range	0.2500 - 0.3500
Beta	0.35
RSI	47.47
Earnings Date	Feb 24, 2026

About Sunzen Group Berhad

Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, and beauty and cosmetic products. It also offers financial consultancy services and licensed money lending activities; manufactures and sells tradition...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Employees: 168
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: SUNZEN

Financial Performance

In 2025, Sunzen Group Berhad's revenue was 80.58 million, a decrease of -15.28% compared to the previous year's 95.12 million. Earnings were 2.59 million, a decrease of -57.10%.